Home/Filings/4/0000950170-25-002072
4//SEC Filing

DOYLE THOMAS JAMES 4

Accession 0000950170-25-002072

CIK 0001422143other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:09 PM ET

Size

9.4 KB

Accession

0000950170-25-002072

Insider Transaction Report

Form 4
Period: 2025-01-02
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Transactions
  • Award

    Common Stock

    2025-01-02+21,25071,892 total
  • Award

    Option to purchase common stock

    2025-01-02+42,50042,500 total
    Exercise: $8.68Exp: 2035-01-01Common Stock (42,500 underlying)
  • Award

    Common Stock

    2025-01-02+21,25093,142 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    500
Footnotes (4)
  • [F1]Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/26, 1/26/27, 1/26/28 and 1/26/29.
  • [F2]Includes 2,499 shares acquired on May 17, 2024 and 50 shares acquired on November 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
  • [F3]Grant of RSUs. The RSUs vest in full on 1/26/27.
  • [F4]This option vests in 48 equal monthly installments commencing on the grant date.

Documents

1 file

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeother

Related Parties

1
  • filerCIK 0001910331

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:09 PM ET
Size
9.4 KB